Morocco: CDG completes exit of healthcare company to Helios

CDG Invest Growth (CIG), the private equity fund manager previously known as CDG Capital Private Equity, and Techniques Science-Santé (T2S) have announced the finalisation of the sale of the latter to a Helios Investment Partners fund.

Helios acquired a majority stake in the largest and most diversified group of medtech companies in Morocco. The consolidated group operates in medical devices, in vitro diagnostic and pharmaceuticals, and comprises four companies: T2S, IM Alliance, Cyclopharma and Binarios.

The consolidated group of companies, under the leadership of Abderraouf Sordo, has positioned itself as a leading medical equipment distributor and maintenance provider throughout French-speaking Africa. Today, it is the largest regional group in the healthcare sector, with annual revenues of over $100 million. The group notably provides a large base of public and private healthcare facilities with access to high-end medical solutions.